世界の非感染性黄斑浮腫治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Non-infectious Macular Edema Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5891
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、109ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、非感染性黄斑浮腫治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗VEGF療法、コルチコステロイド、免疫阻害剤、生物学的製剤、その他）、用途別市場規模（小売薬局、病院薬局、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・非感染性黄斑浮腫治療の市場動向
・企業の競争状況、市場シェア
・非感染性黄斑浮腫治療の種類別市場規模と予測2016-2027（抗VEGF療法、コルチコステロイド、免疫阻害剤、生物学的製剤、その他）
・非感染性黄斑浮腫治療の用途別市場規模と予測2016-2027（小売薬局、病院薬局、その他）
・非感染性黄斑浮腫治療の北米市場規模2016-2027（アメリカ、カナダ）
・非感染性黄斑浮腫治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・非感染性黄斑浮腫治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・非感染性黄斑浮腫治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・非感染性黄斑浮腫治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Allergan、Amgen、Pfizer、Novartis AG、F. Hoffman-La Roche、AbbVie、Bayer AG、Valeant Pharmaceuticals、Alimera Sciences、Clearside Biomedical）
・結論

Non-infectious Macular Edema Treatment refers to the treatment of Non-infectious Macular Edema by drugs or therapies such as anti-VEGF therapy, corticosteroids, immunosuppressive agents, and biological agents. The macula is a region of the center of the retina. Macular edema is the accumulation of fluid in the macula that causes the macula to swell and thicken, thereby distorting vision.

Market Analysis and Insights: Global Non-infectious Macular Edema Treatment Market
The global Non-infectious Macular Edema Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Non-infectious Macular Edema Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Non-infectious Macular Edema Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Non-infectious Macular Edema Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Non-infectious Macular Edema Treatment market.

Global Non-infectious Macular Edema Treatment Scope and Market Size
Non-infectious Macular Edema Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Non-infectious Macular Edema Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Anti-VEGF Therapy
Corticosteroid
Immune Inhibitor
Biological Preparation
Other

Segment by Application
Retail Pharmacy
Hospital Pharmacy
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Allergan
Amgen
Pfizer
Novartis AG
F. Hoffman-La Roche
AbbVie
Bayer AG
Valeant Pharmaceuticals
Alimera Sciences
Clearside Biomedical

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Non-infectious Macular Edema Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Anti-VEGF Therapy
1.2.3 Corticosteroid
1.2.4 Immune Inhibitor
1.2.5 Biological Preparation
1.2.6 Other
1.3 Market by Application
1.3.1 Global Non-infectious Macular Edema Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Retail Pharmacy
1.3.3 Hospital Pharmacy
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Non-infectious Macular Edema Treatment Market Perspective (2016-2027)
2.2 Non-infectious Macular Edema Treatment Growth Trends by Regions
2.2.1 Non-infectious Macular Edema Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Non-infectious Macular Edema Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Non-infectious Macular Edema Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Non-infectious Macular Edema Treatment Industry Dynamic
2.3.1 Non-infectious Macular Edema Treatment Market Trends
2.3.2 Non-infectious Macular Edema Treatment Market Drivers
2.3.3 Non-infectious Macular Edema Treatment Market Challenges
2.3.4 Non-infectious Macular Edema Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Non-infectious Macular Edema Treatment Players by Revenue
3.1.1 Global Top Non-infectious Macular Edema Treatment Players by Revenue (2016-2021)
3.1.2 Global Non-infectious Macular Edema Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Non-infectious Macular Edema Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Non-infectious Macular Edema Treatment Revenue
3.4 Global Non-infectious Macular Edema Treatment Market Concentration Ratio
3.4.1 Global Non-infectious Macular Edema Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Non-infectious Macular Edema Treatment Revenue in 2020
3.5 Non-infectious Macular Edema Treatment Key Players Head office and Area Served
3.6 Key Players Non-infectious Macular Edema Treatment Product Solution and Service
3.7 Date of Enter into Non-infectious Macular Edema Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Non-infectious Macular Edema Treatment Breakdown Data by Type
4.1 Global Non-infectious Macular Edema Treatment Historic Market Size by Type (2016-2021)
4.2 Global Non-infectious Macular Edema Treatment Forecasted Market Size by Type (2022-2027)

5 Non-infectious Macular Edema Treatment Breakdown Data by Application
5.1 Global Non-infectious Macular Edema Treatment Historic Market Size by Application (2016-2021)
5.2 Global Non-infectious Macular Edema Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Non-infectious Macular Edema Treatment Market Size (2016-2027)
6.2 North America Non-infectious Macular Edema Treatment Market Size by Type
6.2.1 North America Non-infectious Macular Edema Treatment Market Size by Type (2016-2021)
6.2.2 North America Non-infectious Macular Edema Treatment Market Size by Type (2022-2027)
6.2.3 North America Non-infectious Macular Edema Treatment Market Size by Type (2016-2027)
6.3 North America Non-infectious Macular Edema Treatment Market Size by Application
6.3.1 North America Non-infectious Macular Edema Treatment Market Size by Application (2016-2021)
6.3.2 North America Non-infectious Macular Edema Treatment Market Size by Application (2022-2027)
6.3.3 North America Non-infectious Macular Edema Treatment Market Size by Application (2016-2027)
6.4 North America Non-infectious Macular Edema Treatment Market Size by Country
6.4.1 North America Non-infectious Macular Edema Treatment Market Size by Country (2016-2021)
6.4.2 North America Non-infectious Macular Edema Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Non-infectious Macular Edema Treatment Market Size (2016-2027)
7.2 Europe Non-infectious Macular Edema Treatment Market Size by Type
7.2.1 Europe Non-infectious Macular Edema Treatment Market Size by Type (2016-2021)
7.2.2 Europe Non-infectious Macular Edema Treatment Market Size by Type (2022-2027)
7.2.3 Europe Non-infectious Macular Edema Treatment Market Size by Type (2016-2027)
7.3 Europe Non-infectious Macular Edema Treatment Market Size by Application
7.3.1 Europe Non-infectious Macular Edema Treatment Market Size by Application (2016-2021)
7.3.2 Europe Non-infectious Macular Edema Treatment Market Size by Application (2022-2027)
7.3.3 Europe Non-infectious Macular Edema Treatment Market Size by Application (2016-2027)
7.4 Europe Non-infectious Macular Edema Treatment Market Size by Country
7.4.1 Europe Non-infectious Macular Edema Treatment Market Size by Country (2016-2021)
7.4.2 Europe Non-infectious Macular Edema Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Non-infectious Macular Edema Treatment Market Size (2016-2027)
8.2 Asia-Pacific Non-infectious Macular Edema Treatment Market Size by Type
8.2.1 Asia-Pacific Non-infectious Macular Edema Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Non-infectious Macular Edema Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Non-infectious Macular Edema Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Non-infectious Macular Edema Treatment Market Size by Application
8.3.1 Asia-Pacific Non-infectious Macular Edema Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Non-infectious Macular Edema Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Non-infectious Macular Edema Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Non-infectious Macular Edema Treatment Market Size by Region
8.4.1 Asia-Pacific Non-infectious Macular Edema Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Non-infectious Macular Edema Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Non-infectious Macular Edema Treatment Market Size (2016-2027)
9.2 Latin America Non-infectious Macular Edema Treatment Market Size by Type
9.2.1 Latin America Non-infectious Macular Edema Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Non-infectious Macular Edema Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Non-infectious Macular Edema Treatment Market Size by Type (2016-2027)
9.3 Latin America Non-infectious Macular Edema Treatment Market Size by Application
9.3.1 Latin America Non-infectious Macular Edema Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Non-infectious Macular Edema Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Non-infectious Macular Edema Treatment Market Size by Application (2016-2027)
9.4 Latin America Non-infectious Macular Edema Treatment Market Size by Country
9.4.1 Latin America Non-infectious Macular Edema Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Non-infectious Macular Edema Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Non-infectious Macular Edema Treatment Market Size (2016-2027)
10.2 Middle East & Africa Non-infectious Macular Edema Treatment Market Size by Type
10.2.1 Middle East & Africa Non-infectious Macular Edema Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Non-infectious Macular Edema Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Non-infectious Macular Edema Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Non-infectious Macular Edema Treatment Market Size by Application
10.3.1 Middle East & Africa Non-infectious Macular Edema Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Non-infectious Macular Edema Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Non-infectious Macular Edema Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Non-infectious Macular Edema Treatment Market Size by Country
10.4.1 Middle East & Africa Non-infectious Macular Edema Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Non-infectious Macular Edema Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Allergan
11.1.1 Allergan Company Details
11.1.2 Allergan Business Overview
11.1.3 Allergan Non-infectious Macular Edema Treatment Introduction
11.1.4 Allergan Revenue in Non-infectious Macular Edema Treatment Business (2016-2021)
11.1.5 Allergan Recent Development
11.2 Amgen
11.2.1 Amgen Company Details
11.2.2 Amgen Business Overview
11.2.3 Amgen Non-infectious Macular Edema Treatment Introduction
11.2.4 Amgen Revenue in Non-infectious Macular Edema Treatment Business (2016-2021)
11.2.5 Amgen Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Non-infectious Macular Edema Treatment Introduction
11.3.4 Pfizer Revenue in Non-infectious Macular Edema Treatment Business (2016-2021)
11.3.5 Pfizer Recent Development
11.4 Novartis AG
11.4.1 Novartis AG Company Details
11.4.2 Novartis AG Business Overview
11.4.3 Novartis AG Non-infectious Macular Edema Treatment Introduction
11.4.4 Novartis AG Revenue in Non-infectious Macular Edema Treatment Business (2016-2021)
11.4.5 Novartis AG Recent Development
11.5 F. Hoffman-La Roche
11.5.1 F. Hoffman-La Roche Company Details
11.5.2 F. Hoffman-La Roche Business Overview
11.5.3 F. Hoffman-La Roche Non-infectious Macular Edema Treatment Introduction
11.5.4 F. Hoffman-La Roche Revenue in Non-infectious Macular Edema Treatment Business (2016-2021)
11.5.5 F. Hoffman-La Roche Recent Development
11.6 AbbVie
11.6.1 AbbVie Company Details
11.6.2 AbbVie Business Overview
11.6.3 AbbVie Non-infectious Macular Edema Treatment Introduction
11.6.4 AbbVie Revenue in Non-infectious Macular Edema Treatment Business (2016-2021)
11.6.5 AbbVie Recent Development
11.7 Bayer AG
11.7.1 Bayer AG Company Details
11.7.2 Bayer AG Business Overview
11.7.3 Bayer AG Non-infectious Macular Edema Treatment Introduction
11.7.4 Bayer AG Revenue in Non-infectious Macular Edema Treatment Business (2016-2021)
11.7.5 Bayer AG Recent Development
11.8 Valeant Pharmaceuticals
11.8.1 Valeant Pharmaceuticals Company Details
11.8.2 Valeant Pharmaceuticals Business Overview
11.8.3 Valeant Pharmaceuticals Non-infectious Macular Edema Treatment Introduction
11.8.4 Valeant Pharmaceuticals Revenue in Non-infectious Macular Edema Treatment Business (2016-2021)
11.8.5 Valeant Pharmaceuticals Recent Development
11.9 Alimera Sciences
11.9.1 Alimera Sciences Company Details
11.9.2 Alimera Sciences Business Overview
11.9.3 Alimera Sciences Non-infectious Macular Edema Treatment Introduction
11.9.4 Alimera Sciences Revenue in Non-infectious Macular Edema Treatment Business (2016-2021)
11.9.5 Alimera Sciences Recent Development
11.10 Clearside Biomedical
11.10.1 Clearside Biomedical Company Details
11.10.2 Clearside Biomedical Business Overview
11.10.3 Clearside Biomedical Non-infectious Macular Edema Treatment Introduction
11.10.4 Clearside Biomedical Revenue in Non-infectious Macular Edema Treatment Business (2016-2021)
11.10.5 Clearside Biomedical Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Non-infectious Macular Edema Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Anti-VEGF Therapy
Table 3. Key Players of Corticosteroid
Table 4. Key Players of Immune Inhibitor
Table 5. Key Players of Biological Preparation
Table 6. Key Players of Other
Table 7. Global Non-infectious Macular Edema Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Non-infectious Macular Edema Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Non-infectious Macular Edema Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Non-infectious Macular Edema Treatment Market Share by Regions (2016-2021)
Table 11. Global Non-infectious Macular Edema Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Non-infectious Macular Edema Treatment Market Share by Regions (2022-2027)
Table 13. Non-infectious Macular Edema Treatment Market Trends
Table 14. Non-infectious Macular Edema Treatment Market Drivers
Table 15. Non-infectious Macular Edema Treatment Market Challenges
Table 16. Non-infectious Macular Edema Treatment Market Restraints
Table 17. Global Non-infectious Macular Edema Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Non-infectious Macular Edema Treatment Market Share by Players (2016-2021)
Table 19. Global Top Non-infectious Macular Edema Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Non-infectious Macular Edema Treatment as of 2020)
Table 20. Ranking of Global Top Non-infectious Macular Edema Treatment Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Non-infectious Macular Edema Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Non-infectious Macular Edema Treatment Product Solution and Service
Table 24. Date of Enter into Non-infectious Macular Edema Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Non-infectious Macular Edema Treatment Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Non-infectious Macular Edema Treatment Revenue Market Share by Type (2016-2021)
Table 28. Global Non-infectious Macular Edema Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Non-infectious Macular Edema Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Non-infectious Macular Edema Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Non-infectious Macular Edema Treatment Revenue Market Share by Application (2016-2021)
Table 32. Global Non-infectious Macular Edema Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Non-infectious Macular Edema Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Non-infectious Macular Edema Treatment Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Non-infectious Macular Edema Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Non-infectious Macular Edema Treatment Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Non-infectious Macular Edema Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Non-infectious Macular Edema Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Non-infectious Macular Edema Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Non-infectious Macular Edema Treatment Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Non-infectious Macular Edema Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Non-infectious Macular Edema Treatment Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Non-infectious Macular Edema Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Non-infectious Macular Edema Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Non-infectious Macular Edema Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Non-infectious Macular Edema Treatment Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Non-infectious Macular Edema Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Non-infectious Macular Edema Treatment Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Non-infectious Macular Edema Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Non-infectious Macular Edema Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Non-infectious Macular Edema Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Non-infectious Macular Edema Treatment Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Non-infectious Macular Edema Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Non-infectious Macular Edema Treatment Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Non-infectious Macular Edema Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Non-infectious Macular Edema Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Non-infectious Macular Edema Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Non-infectious Macular Edema Treatment Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Non-infectious Macular Edema Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Non-infectious Macular Edema Treatment Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Non-infectious Macular Edema Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Non-infectious Macular Edema Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Non-infectious Macular Edema Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 64. Allergan Company Details
Table 65. Allergan Business Overview
Table 66. Allergan Non-infectious Macular Edema Treatment Product
Table 67. Allergan Revenue in Non-infectious Macular Edema Treatment Business (2016-2021) & (US$ Million)
Table 68. Allergan Recent Development
Table 69. Amgen Company Details
Table 70. Amgen Business Overview
Table 71. Amgen Non-infectious Macular Edema Treatment Product
Table 72. Amgen Revenue in Non-infectious Macular Edema Treatment Business (2016-2021) & (US$ Million)
Table 73. Amgen Recent Development
Table 74. Pfizer Company Details
Table 75. Pfizer Business Overview
Table 76. Pfizer Non-infectious Macular Edema Treatment Product
Table 77. Pfizer Revenue in Non-infectious Macular Edema Treatment Business (2016-2021) & (US$ Million)
Table 78. Pfizer Recent Development
Table 79. Novartis AG Company Details
Table 80. Novartis AG Business Overview
Table 81. Novartis AG Non-infectious Macular Edema Treatment Product
Table 82. Novartis AG Revenue in Non-infectious Macular Edema Treatment Business (2016-2021) & (US$ Million)
Table 83. Novartis AG Recent Development
Table 84. F. Hoffman-La Roche Company Details
Table 85. F. Hoffman-La Roche Business Overview
Table 86. F. Hoffman-La Roche Non-infectious Macular Edema Treatment Product
Table 87. F. Hoffman-La Roche Revenue in Non-infectious Macular Edema Treatment Business (2016-2021) & (US$ Million)
Table 88. F. Hoffman-La Roche Recent Development
Table 89. AbbVie Company Details
Table 90. AbbVie Business Overview
Table 91. AbbVie Non-infectious Macular Edema Treatment Product
Table 92. AbbVie Revenue in Non-infectious Macular Edema Treatment Business (2016-2021) & (US$ Million)
Table 93. AbbVie Recent Development
Table 94. Bayer AG Company Details
Table 95. Bayer AG Business Overview
Table 96. Bayer AG Non-infectious Macular Edema Treatment Product
Table 97. Bayer AG Revenue in Non-infectious Macular Edema Treatment Business (2016-2021) & (US$ Million)
Table 98. Bayer AG Recent Development
Table 99. Valeant Pharmaceuticals Company Details
Table 100. Valeant Pharmaceuticals Business Overview
Table 101. Valeant Pharmaceuticals Revenue in Non-infectious Macular Edema Treatment Business (2016-2021) & (US$ Million)
Table 102. Valeant Pharmaceuticals Recent Development
Table 103. Alimera Sciences Company Details
Table 104. Alimera Sciences Business Overview
Table 105. Alimera Sciences Non-infectious Macular Edema Treatment Product
Table 106. Alimera Sciences Revenue in Non-infectious Macular Edema Treatment Business (2016-2021) & (US$ Million)
Table 107. Alimera Sciences Recent Development
Table 108. Clearside Biomedical Company Details
Table 109. Clearside Biomedical Business Overview
Table 110. Clearside Biomedical Non-infectious Macular Edema Treatment Product
Table 111. Clearside Biomedical Revenue in Non-infectious Macular Edema Treatment Business (2016-2021) & (US$ Million)
Table 112. Clearside Biomedical Recent Development
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Non-infectious Macular Edema Treatment Market Share by Type: 2020 VS 2027
Figure 2. Anti-VEGF Therapy Features
Figure 3. Corticosteroid Features
Figure 4. Immune Inhibitor Features
Figure 5. Biological Preparation Features
Figure 6. Other Features
Figure 7. Global Non-infectious Macular Edema Treatment Market Share by Application: 2020 VS 2027
Figure 8. Retail Pharmacy Case Studies
Figure 9. Hospital Pharmacy Case Studies
Figure 10. Other Case Studies
Figure 11. Non-infectious Macular Edema Treatment Report Years Considered
Figure 12. Global Non-infectious Macular Edema Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Non-infectious Macular Edema Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Non-infectious Macular Edema Treatment Market Share by Regions: 2020 VS 2027
Figure 15. Global Non-infectious Macular Edema Treatment Market Share by Regions (2022-2027)
Figure 16. Global Non-infectious Macular Edema Treatment Market Share by Players in 2020
Figure 17. Global Top Non-infectious Macular Edema Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Non-infectious Macular Edema Treatment as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Non-infectious Macular Edema Treatment Revenue in 2020
Figure 19. Global Non-infectious Macular Edema Treatment Revenue Market Share by Type (2016-2021)
Figure 20. Global Non-infectious Macular Edema Treatment Revenue Market Share by Type (2022-2027)
Figure 21. North America Non-infectious Macular Edema Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Non-infectious Macular Edema Treatment Market Share by Type (2016-2027)
Figure 23. North America Non-infectious Macular Edema Treatment Market Share by Application (2016-2027)
Figure 24. North America Non-infectious Macular Edema Treatment Market Share by Country (2016-2027)
Figure 25. United States Non-infectious Macular Edema Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Non-infectious Macular Edema Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Non-infectious Macular Edema Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Non-infectious Macular Edema Treatment Market Share by Type (2016-2027)
Figure 29. Europe Non-infectious Macular Edema Treatment Market Share by Application (2016-2027)
Figure 30. Europe Non-infectious Macular Edema Treatment Market Share by Country (2016-2027)
Figure 31. Germany Non-infectious Macular Edema Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Non-infectious Macular Edema Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Non-infectious Macular Edema Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Non-infectious Macular Edema Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Non-infectious Macular Edema Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Non-infectious Macular Edema Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Non-infectious Macular Edema Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Non-infectious Macular Edema Treatment Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Non-infectious Macular Edema Treatment Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Non-infectious Macular Edema Treatment Market Share by Region (2016-2027)
Figure 41. China Non-infectious Macular Edema Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Non-infectious Macular Edema Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Non-infectious Macular Edema Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Non-infectious Macular Edema Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Non-infectious Macular Edema Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Non-infectious Macular Edema Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Non-infectious Macular Edema Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Non-infectious Macular Edema Treatment Market Share by Type (2016-2027)
Figure 49. Latin America Non-infectious Macular Edema Treatment Market Share by Application (2016-2027)
Figure 50. Latin America Non-infectious Macular Edema Treatment Market Share by Country (2016-2027)
Figure 51. Mexico Non-infectious Macular Edema Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Non-infectious Macular Edema Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Non-infectious Macular Edema Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Non-infectious Macular Edema Treatment Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Non-infectious Macular Edema Treatment Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Non-infectious Macular Edema Treatment Market Share by Country (2016-2027)
Figure 57. Turkey Non-infectious Macular Edema Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Non-infectious Macular Edema Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Non-infectious Macular Edema Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Allergan Revenue Growth Rate in Non-infectious Macular Edema Treatment Business (2016-2021)
Figure 61. Amgen Revenue Growth Rate in Non-infectious Macular Edema Treatment Business (2016-2021)
Figure 62. Pfizer Revenue Growth Rate in Non-infectious Macular Edema Treatment Business (2016-2021)
Figure 63. Novartis AG Revenue Growth Rate in Non-infectious Macular Edema Treatment Business (2016-2021)
Figure 64. F. Hoffman-La Roche Revenue Growth Rate in Non-infectious Macular Edema Treatment Business (2016-2021)
Figure 65. AbbVie Revenue Growth Rate in Non-infectious Macular Edema Treatment Business (2016-2021)
Figure 66. Bayer AG Revenue Growth Rate in Non-infectious Macular Edema Treatment Business (2016-2021)
Figure 67. Valeant Pharmaceuticals Revenue Growth Rate in Non-infectious Macular Edema Treatment Business (2016-2021)
Figure 68. Alimera Sciences Revenue Growth Rate in Non-infectious Macular Edema Treatment Business (2016-2021)
Figure 69. Clearside Biomedical Revenue Growth Rate in Non-infectious Macular Edema Treatment Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

以下、関連資料のご紹介

世界の加齢黄斑変性症用治療市場規模・現状・予測（2021年-2027年）

Global Age Related Macular Degeneration Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3771 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、加齢黄斑変性症用治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ルセンティス、アイリーア、アバスチン、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、ア...

世界の加齢黄斑変性症（AMD）治療市場規模・現状・予測（2021年-2027年）

Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-5569 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、加齢黄斑変性症（AMD）治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ウェットAMD、ドライAMD）、用途別市場規模（病院、診療所、研究機関、その他）、主要地域別市場規模（北米、アメリカ、欧州、...

世界の嚢胞性浮腫臨床試験市場規模・現状・予測（2021年-2027年）

Global Cystoid Edema Clinical Trials Market Size, Status and Forecast 2021-2027
QFJ1-4093 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、嚢胞性浮腫臨床試験の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（トラクション糖尿病、糖尿病性網膜症、嚢胞性）、用途別市場規模（病院、医学研究機関、その他）、主要地域別市場規模（北米、アメリカ、欧州、...

世界の浮腫臨床試験市場規模・現状・予測（2021年-2027年）

Global Edema Clinical Trials Market Size, Status and Forecast 2021-2027
QFJ1-4172 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、浮腫臨床試験の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（全身用、局所用）、用途別市場規模（病院、医学研究機関、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、...

世界のウェット型黄斑変性症市場規模・現状・予測（2021年-2027年）

Global Wet Macular Degeneration Market Size, Status and Forecast 2021-2027
QFJ1-6069 2021年6月 118Pages
QYResearch社発行の本調査レポートでは、ウェット型黄斑変性症の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ルセンティス、アイレア、アバスチン、その他）、用途別市場規模（病院、診療所、研究機関、学術機関）、主要地域別市場規模（北米、アメリカ...

世界の黄斑変性症治療薬パイプライン市場規模・現状・予測（2021年-2027年）

Global Macular Degeneration Drug Pipeline Market Size, Status and Forecast 2021-2027
QFJ1-4452 2021年6月 126Pages
QYResearch社発行の本調査レポートでは、黄斑変性症治療薬パイプラインの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（遺伝子治療、小分子、幹細胞治療、遺伝子治療）、用途別市場規模（病院、研究所、商業、その他）、主要地域別市場規模（北米、アメリ...

世界の感染症治療薬市場規模・現状・予測（2021年-2027年）

Global Infectious Disease Drugs Market Size, Status and Forecast 2021-2027
QFJ1-5800 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、感染症治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗菌剤、抗ウイルス剤、抗寄生虫剤、抗真菌剤、その他）、用途別市場規模（HIV、マラリア、肝炎、インフルエンザ、HPV、結核、その他）、主要地...

世界のIVD感染症市場規模・現状・予測（2021年-2027年）

Global IVD Infectious Diseases Market Size, Status and Forecast 2021-2027
QFJ1-4399 2021年6月 116Pages
QYResearch社発行の本調査レポートでは、IVD感染症の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（免疫化学、分子診断）、用途別市場規模（臨床検査室、診断センター）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド...

世界の感染症用体外診断薬市場規模・現状・予測（2021年-2027年）

Global Infectious Diseases In Vitro Diagnostics Market Size, Status and Forecast 2021-2027
QFJ1-4363 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、感染症用体外診断薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（MRSA、連鎖球菌、結核＆薬剤耐性結核、消化器パネル検査、HIV、C型肝炎、その他）、用途別市場規模（免疫化学、分子診断、微生物学、そ...

世界の感染症診断市場規模・現状・予測（2021年-2027年）

Global Infectious Disease Diagnosis Market Size, Status and Forecast 2021-2027
QFJ1-4361 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、感染症診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（尿、血液、その他）、用途別市場規模（病院＆外傷センター、診断研究所、リハビリテーションセンター）、主要地域別市場規模（北米、アメリカ、欧州、ア...

世界の加齢黄斑変性症用治療市場規模・現状・予測（2021年-2027年） Age-related macular degeneration (AMD) is a disease that blurs the sharp, central vision you need for “straight-ahead” activities such as reading, sewing, and driving. AMD affects the macula, the part of the eye that allows you to see fine detail. Market Analysis and Insights: Global Age Related Mac…
世界の加齢黄斑変性症（AMD）治療市場規模・現状・予測（2021年-2027年） Age-related macular degeneration is a bilateral ocular condition in which the central area of the retina, known as the macula, is affected. Age-related macular degeneration is a progressive condition, and it is common among the geriatric population. The growing geriatric population is contributing t…
世界の嚢胞性浮腫臨床試験市場規模・現状・予測（2021年-2027年） Macular edema is the accumulation of fluid in the macular retina or under the retina. Macular edema is an important cause of vision loss.Diabetic macular edema is a common ocular complication of diabetes.It causes blood vessels in the retina at the back of the eye to leak, causing swelling. Market A…
世界の浮腫臨床試験市場規模・現状・予測（2021年-2027年） Edema refers to the body's tissues clearance with the accumulation of excess fluid organizational swelling.Edema can be divided into systemic and local.Systemic edema (usually pitting) occurs when fluid is distributed diffusely between tissues in the body.Fluid accumulation in local interstitial spa…
若年性黄斑変性症治療のグローバル市場調査 2019年 The global Juvenile Macular Degeneration Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Juvenile Macular Degeneration Treatment volume and value at global level, regional level and compan…